Shopping Cart
Remove All
Your shopping cart is currently empty
NT1-O12B, an endogenous neurotransmitter-derived lipidoid (NT-lipidoid), serves as a highly efficient carrier for enhancing the transportation of various blood-brain barrier (BBB)-impermeable cargos to the brain. Incorporating NT1-O12B into BBB-impermeable lipid nanoparticles (LNPs) enables these LNPs to effectively traverse the BBB. In addition to enabling cargo passage through the BBB, NT-lipidoid formulations facilitate efficient delivery of the cargo into neuronal cells for purposes such as functional gene silencing or gene recombination[1].
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | $291 | Inquiry | Inquiry | |
| 10 mg | $481 | Inquiry | Inquiry | |
| 25 mg | $913 | Inquiry | Inquiry | |
| 50 mg | $1,410 | Inquiry | Inquiry | |
| 100 mg | $1,990 | Inquiry | Inquiry | |
| 1 mL x 10 mM (in DMSO) | $456 | Inquiry | Inquiry |
| Description | NT1-O12B, an endogenous neurotransmitter-derived lipidoid (NT-lipidoid), serves as a highly efficient carrier for enhancing the transportation of various blood-brain barrier (BBB)-impermeable cargos to the brain. Incorporating NT1-O12B into BBB-impermeable lipid nanoparticles (LNPs) enables these LNPs to effectively traverse the BBB. In addition to enabling cargo passage through the BBB, NT-lipidoid formulations facilitate efficient delivery of the cargo into neuronal cells for purposes such as functional gene silencing or gene recombination[1]. |
| In vitro | NT1-O12B indicates a lipidoid containing a tryptamine head group and a hydrophobic tail group containing 12 carbon atoms[1]. |
| In vivo | The process encapsulates Amphotericin B (AmB) utilizing NT1-lipidoids—specifically NT1-O12B, NT1-O14B, NT1-O16B, and NT1-O18B following a method akin to DiR encapsulation. Among these, NT1-O12B serves as an effective dopant for brain delivery, demonstrating the highest DiR fluorescence intensity compared to the others. Integrating NT1-O12B with the blood-brain barrier (BBB)-impermeable lipidoid PBA-Q76-O16B produces an AmB formulation capable of crossing the BBB. This technique significantly enhances AmB presence in brain tissue, reaching concentrations up to 300 ng/g (AmB/tissue) and achieving a delivery efficiency of approximately 0.135% of the injected dose 24 hours post intravenous administration of AmB (5 mg/kg)[1]. |
| Synonyms | NT1-O12B |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| Solubility Information | DMSO: 200 mg/mL, Sonication is recommended. |
| In Vivo Formulation | 10% DMSO+90% Corn Oil: 5 mg/mL, Sonication is recommeded. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.